輸入代號或公司名稱後按 Enter
ZLAB

Zai Lab Ltd

+1.09 (+4.42%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834 · 外國發行人(20-F / 40-F)
25.76USD236K成交股數市值本益比(近四季)股價營收比-3.1%營收年增(近四季)2026-11-05下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收106M-3%95.6M-10%127M+25%115M+15%109M+25%106M+60%102M+47%100M+45%87.1M65.8M69.2M68.9M
營業成本48.2M38.3M62.3M46.8M43.0M38.5M36.6M35.1M33.6M25.2M25.5M23.8M
毛利57.6M-13%57.2M-15%64.8M-1%68.6M+6%66.1M+23%67.2M+66%65.3M+49%65.0M+44%53.5M40.6M43.7M45.1M
毛利率54.5%59.9%51.0%59.5%60.6%63.6%64.1%64.9%61.4%61.7%63.2%65.5%
研發費用61.8M65.6M61.6M47.9M50.6M60.7M66.0M61.6M54.6M81.9M58.8M76.7M
銷售管理費用72.9M65.1M73.0M70.1M71.0M63.4M67.2M79.7M69.2M82.6M68.6M67.9M
營業利益−76.5M+39%−69.4M+23%−69.4M+2%−48.8M-36%−54.9M-22%−56.3M-55%−67.9M-19%−76.1M-15%−70.3M−124M−83.6M−89.5M
營業利益率-72.3%-72.6%-54.6%-42.3%-50.3%-53.3%-66.6%-76.0%-80.7%-188.3%-120.7%-130.0%
稅後淨利−50.8M+25%−51.0M+5%−50.4M+21%−36.0M-55%−40.7M-24%−48.4M-49%−41.7M-40%−80.3M-34%−53.5M−95.4M−69.2M−121M
淨利率-48.1%-53.4%-39.6%-31.2%-37.3%-45.8%-40.9%-80.2%-61.4%-144.9%-99.9%-175.6%
稀釋 EPS-0.05+25%-0.05+25%-0.05+25%-0.03-63%-0.04-20%-0.04-60%-0.04-43%-0.08-38%-0.05-0.10-0.07-0.13
稀釋股數1.12B1.11B1.10B1.10B1.09B1.08B982M976M973M966M969M965M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金608M651M680M717M732M757M616M630M651M790M789M859M
應收帳款69.6M54.1M106M85.4M88.5M76.6M50.0M69.6M60.4M59.2M41.6M47.3M
存貨90.9M86.0M74.7M67.1M61.7M53.1M39.5M41.8M37.9M44.8M44.2M36.4M
總資產1.1B1.1B1.2B1.2B1.2B1.2B985M987M988M1.0B1.0B1.1B
有息負債
總負債468M434M457M399M372M363M318M283M226M240M163M174M
股東權益607M662M716M760M792M811M668M704M762M796M881M932M
負債比43.5%39.6%39.0%34.4%32.0%30.9%32.2%28.7%22.9%23.2%15.6%15.7%
淨現金(現金 − 有息負債)

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−11.9M-81%−61.7M−90.1M
資本支出1.2M1.5M974K
自由現金流−13.1M-79%−63.2M−91.1M
折舊攤銷3.9M3.5M3.0M
買回庫藏股
現金股利
自由現金流率-13.7%-59.9%-104.5%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

產品/服務2025 年度 · 268M
Vyvgart Vyvgart Hytrulo94.2M35.1%+0.6%
Nuzyra60.8M22.7%+40.8%
Optune48.3M18.0%+19.4%
Qinlock35.6M13.3%+23.5%
XACDURO22.9M8.5%+593.3%
AUGTYRO5.5M2.1%+409.0%
Product And Service Other717K0.3%
Zejula 小計189M70.5%+1.0%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025457M+15.0%−176M-38.4%-0.16−159M
FY2024398M+49.1%−257M-64.7%-0.26−221M
FY2023267M+25.4%−335M-125.5%-0.35−205M
FY2022213M+47.6%−443M-208.4%-0.46−392M
FY2021144M+194.3%−705M-488.9%-0.76−568M
FY202049.0M+277.0%−269M-549.3%-0.35−226M
FY201913.0M+9965.9%−195M-1,502.3%-3.03−197M
FY2018129K−139M-107,810.1%-2.64−108M